Mestinon and Movement disorder - a phase IV clinical study of FDA data

Summary:

Movement disorder is reported as a side effect among people who take Mestinon (pyridostigmine bromide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Centrum Silver, and have High blood pressure.

The phase IV clinical study analyzes which people have Movement disorder when taking Mestinon. It is created by eHealthMe based on reports of 5,613 people who have side effects when taking Mestinon from the FDA, and is updated regularly.

What is Mestinon?

Mestinon has active ingredients of pyridostigmine bromide. It is often used in myasthenia gravis. eHealthMe is studying from 5,948 Mestinon users. Check the latest studies of Mestinon.

What is Movement disorder?

Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness) is found to be associated with 1,381 drugs and 1,501 conditions by eHealthMe. Check the latest studies of Movement disorder.

On Jul, 18, 2026

5,613 people reported to have side effects when taking Mestinon.
Among them, 25 people (0.45%) have Movement disorder.

Among these 25 people:

How long have people been on Mestinon when they have Movement disorder? *

What is the gender of people who have Movement disorder when taking Mestinon? *

female: 56 %
male: 44 %

What is the age of people who have Movement disorder when taking Mestinon? *

What are other drugs people take besides Mestinon? *

What are other side effects people have besides Movement disorder? *

Weakness: 8 people, 32.00%
Headache (pain in head): 7 people, 28.00%
Fall: 6 people, 24.00%
Dizziness: 6 people, 24.00%
High Blood Pressure: 5 people, 20.00%
Speech Disorder: 5 people, 20.00%
Tremor (trembling or shaking movements in one or more parts of your body): 4 people, 16.00%
Balance Disorder: 4 people, 16.00%
Visual Impairment: 4 people, 16.00%
Speech Impairment (Adult) (inability to speak (adult)): 4 people, 16.00%

What are the existing conditions these people have? *

High Blood Pressure: 6 people, 24.00%
Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 4 people, 16.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 12.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 12.00%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 12.00%
Joint Pain: 3 people, 12.00%
High Blood Cholesterol: 3 people, 12.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 8.00%
Depression: 2 people, 8.00%
Diabetes: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mestinon and have Movement disorder?

- Check whether Movement disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mestinon:

Mestinon (5,948 reports)

Browse all side effects of Mestinon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Movement disorder:

Movement disorder (1,381 drugs)

Browse all the conditions that are associated with Movement disorder:

Movement disorder (1,501 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pyridostigmine bromide (the active ingredients of Mestinon) and Mestinon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.